Higenamine: Beta-2 Agonist from Plants — Banned by WADA, FDA-Questionable Status
⚡ 60-Second Summary
Higenamine (norcoclaurine) is a benzylisoquinoline alkaloid naturally occurring in numerous plants including aconite (Aconitum), lotus seeds, magnolia, and various traditional medicines. It is a beta-2 adrenergic receptor agonist — the same receptor targeted by pharmaceutical bronchodilators like salbutamol (albuterol). This activity produces bronchodilation, increased heart rate and contractility, and potentially fat mobilization.
Higenamine is banned by WADA (World Anti-Doping Agency) since 2017, as a non-selective beta-agonist with performance-enhancing potential. FDA has questioned its legality as a dietary supplement ingredient. It appeared in pre-workout supplements often unlabeled or labeled as 'norcoclaurine' or 'lotus seed extract.'
The safety concern is cardiovascular — beta-2 agonist activation increases heart rate and can trigger arrhythmias, particularly at supplement doses. Aconite (the primary higenamine source) is one of the most toxic plants known for cardiac alkaloids — while higenamine is different from aconite's primary cardiotoxins (aconitine), higenamine-containing extracts may contain trace cardiac toxins.
What is Higenamine?
Higenamine was introduced to sports nutrition supplements around 2013–2015 following DMAA enforcement, as manufacturers sought DMAA alternatives. Its WADA prohibition in 2017 made it a banned stimulant in competitive sports.
Cohen et al. 2021 (JAMA Internal Medicine) found higenamine in 24 of 24 tested supplements claiming plant-based beta-adrenergic activity — often at much higher doses than labeled.
Evidence-based benefits
Beta-2 Agonist Activity (Pharmacological)
Higenamine's pharmacological activity as a beta-2 agonist is established: it produces bronchodilation, heart rate increase, and beta-adrenergic effects. This pharmacological activity is the basis for WADA prohibition — beta agonists are performance-enhancing.
Fat Oxidation (Animal/Theoretical)
Beta-2 activation increases cAMP and activates hormone-sensitive lipase — theoretically promoting fat mobilization. No human RCTs specific to higenamine for fat loss.
Adverse Cardiovascular Events
Multiple adverse event reports and case studies document palpitations, tachycardia, and concerning cardiovascular effects from higenamine-containing supplements.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Form | Dose | Notes | Status |
| Higenamine (any form) | DO NOT USE in tested sports; use with caution generally | WADA banned; FDA-questionable status; cardiovascular safety concerns | Illegal in sports; regulatory status uncertain in supplements |
| Lotus Seed Extract / Norcoclaurine | DO NOT USE | Higenamine marketed under alternative names | Often in pre-workout blends without adequate disclosure |
How much should you take?
- DO NOT USE if subject to sports drug testing — WADA prohibited stimulant
- For supplement users: be aware that products claiming 'lotus seed extract,' 'norcoclaurine,' or 'natural beta-adrenergic support' may contain higenamine
- Report adverse cardiovascular effects (palpitations, chest pain, irregular heartbeat) immediately to healthcare provider
- For pre-workout stimulation: use caffeine, theacrine, or Dynamine — legal, better-studied alternatives
Cohen et al. (2021) found that supplements claiming natural beta-adrenergic activity often contained higenamine at higher amounts than labeled, sometimes combined with other stimulants. Quality control is poor in this supplement category.
Safety and side effects
Common side effects
- Cardiovascular: tachycardia, palpitations, elevated blood pressure, arrhythmia risk
- Bronchodilation — respiratory effects
- Sweating, tremor
- WADA-prohibited stimulant — career risk for competitive athletes
- Aconite-derived extracts may contain trace cardiotoxic alkaloids
Serious risks
Higenamine's cardiovascular adverse effect profile warrants caution. For competitive athletes, the WADA prohibition is absolute — there is no acceptable use case in tested sports.
Drug and nutrient interactions
- Other stimulants (caffeine, DMAA, DMHA) — additive cardiovascular stimulation
- Beta-blockers — direct mechanistic antagonism
- Antiarrhythmics — possible interference with cardiac rhythm management
- MAO inhibitors — adrenergic effects amplified
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| Researchers and clinicians studying beta-adrenergic pharmacology of plant alkaloids (academic context only) | ALL competitive athletes in WADA-tested sports — strictly prohibited |
| Consumers seeking pre-workout energy — safer legal alternatives exist | |
| People with cardiovascular conditions — beta-adrenergic stimulation contraindicated | |
| Pregnant women — avoid |
Frequently asked questions
Why was higenamine banned by WADA?
WADA added higenamine to the 2017 Prohibited List as a non-selective beta agonist. Beta agonists are prohibited in sport because they enhance oxygen delivery (through bronchodilation) and may improve cardiac performance. WADA's prohibition covers all beta agonists unless granted a therapeutic use exemption (TUE). Athletes have been sanctioned for higenamine use in pre-workout supplements, sometimes unaware their product contained it.
Is higenamine legal as a dietary supplement?
This is actively debated. FDA has not formally banned higenamine (unlike DMAA), but has questioned whether it qualifies as a lawful dietary ingredient under the Dietary Supplement Health and Education Act (DSHEA), since it was not marketed as a supplement before 1994 and does not clearly meet the botanical ingredient requirements. Several FDA warning letters reference higenamine in dietary supplements as being of concern. Its legal status is uncertain.
How does higenamine compare to caffeine?
Both are stimulants but with different mechanisms. Caffeine blocks adenosine receptors (reducing fatigue signaling). Higenamine directly activates beta-2 adrenergic receptors (the same receptors that salbutamol/albuterol activates for asthma treatment). The receptor activation approach makes higenamine's cardiovascular effects more direct and potentially more severe than caffeine at equivalent stimulant doses. This pharmacological distinction is why WADA prohibits higenamine but not caffeine.
Can athletes take any beta agonists in sport?
WADA allows certain inhaled beta agonists (salbutamol, formoterol, salmeterol) when medically needed for asthma, with dose restrictions and sometimes therapeutic use exemptions (TUEs). Oral or systemic beta agonists including higenamine are prohibited. Athletes with asthma requiring inhaled beta agonists should apply for TUE documentation with their sport federation.
Related ingredients
Caffeine Anhydrous
Legal stimulant alternative with extensive safety and performance evidence.
Theacrine
Legal alkaloid stimulant with habituation-resistance properties.
Synephrine (Bitter Orange)
Legal adrenergic supplement with different receptor profile; also some regulatory attention.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.